Inventor · disambiguated record
Venkataiah Bollu
Also filed as: BOLLU VENKATAIAH
26 granted patents·7 pending applications·105 citations·filing 2009–2024
94Inventor score
Files withSAMUMED LLC15DART NEUROSCIENCE CAYMAN LTD5BIOSPLICE THERAPEUTICS INC4DART NEUROSCIENCE LLC3BOLLU VENKATAIAH2
Top patents by PatentIndex Score
33 records- 0198US9745271B25-substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2015·Granted Aug 29, 2017·58 cites·16 claims
- 0295US11548872B2Isoquinolin-3-yl carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Jan 10, 2023·2 cites·37 claims
- 0395US9951048B1Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2017·Granted Apr 24, 2018·13 cites·30 claims
- 0493US10947217B2Isoquinolin-3-YL carboxamides and preparation and use thereofSAMUMED LLC·Filed 2019·Granted Mar 16, 2021·4 cites·40 claims
- 0588US10544128B2Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted Jan 28, 2020·2 cites·42 claims
- 0687US10100038B2Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted Oct 16, 2018·3 cites·30 claims
- 0787US2025122172A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2024·Application pending·0 cites
- 0886US10106527B2Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2017·Granted Oct 23, 2018·3 cites·39 claims
- 0985US12281097B2Isoquinolin-3-yl carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2022·Granted Apr 22, 2025·0 cites·21 claims
- 1082US8618154B2LXR modulatorsBUSCH BRETT B·Filed 2010·Granted Dec 31, 2013·6 cites·30 claims
- 1181US9120770B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Sep 1, 2015·3 cites·30 claims
- 1279US2023075774A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE LLC·Filed 2022·Application pending·0 cites
- 1378US10934297B25-heteroaryl substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2019·Granted Mar 2, 2021·1 cites·28 claims
- 1478US9040692B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted May 26, 2015·2 cites·1 claims
- 1576US10195185B23-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Feb 5, 2019·1 cites·22 claims
- 1675US10604514B26-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted Mar 31, 2020·1 cites·35 claims
- 1774US9573937B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Feb 21, 2017·1 cites·20 claims
- 1873US11279691B2Substituted pyridine and pyrazine compounds as PDE4 inhibitorsDART NEUROSCIENCE LLC·Filed 2019·Granted Mar 22, 2022·0 cites·4 claims
- 1971US10392383B23-(1H-benzo[d]imidazol-2-yl)-1H-pyrazolo[4,3-b]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Aug 27, 2019·1 cites·23 claims
- 2069US10329309B23-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Jun 25, 2019·1 cites·23 claims
- 2169US8785488B2Triazole and imidazole derivatives for use as TGR5 agonists in the treatment of diabetes and obesityBOLLU VENKATAIAH·Filed 2010·Granted Jul 22, 2014·3 cites·14 claims
- 2265US2018346448A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2018·Application pending·0 cites
- 2364US11713320B25-heteroaryl substituted indazole-3-carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2020·Granted Aug 1, 2023·0 cites·24 claims
- 2464US2016009691A1Substituted pyridine and pyrazine compounds as pde4 inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Application pending·0 cites
- 2561US2023192686A11h-pyrrolo[2,3-b]pyridines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2658US2014163081A1Lxr modulatorsEXELIXIS PATENT CO LLC·Filed 2013·Application pending·0 cites
- 2756US10669240B25-substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 2851US8163771B211 β-HSD1 modulatorsMARTIN RICHARD·Filed 2009·Granted Apr 24, 2012·0 cites·40 claims
- 2950US2015299136A1Lxr modulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3045US10703748B2Diazanaphthalen-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted Jul 7, 2020·0 cites·17 claims
- 3144US10653688B26-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted May 19, 2020·0 cites·24 claims
- 3239US10188634B23-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereofSAMUMED LLC·Filed 2016·Granted Jan 29, 2019·0 cites·22 claims
- 3331US8846739B2TGR5 agonistsBOLLU VENKATAIAH·Filed 2010·Granted Sep 30, 2014·0 cites·23 claims
Join the waitlist — get patent alerts
Get an alert when Venkataiah Bollu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →